Utilizing AI and Nanotechnology Solutions to Propel Progress in Cancer Diagnostics, Therapeutics, and Integrated Theranostics

Abstract

This chapter explores the dynamic convergence of nanotechnology and artificial intelligence (AI) in advancing cancer diagnosis and therapy. Nanotechnology employs nanoparticles for theragnostic applications, integrating diagnostic and therapeutic roles. Customized nanoparticles enable precise imaging and targeted treatment, minimizing harm to healthy tissue. Passive and active targeting optimize drug delivery, combat multidrug resistance, and introduce personalized treatment. AI-driven techniques analyze omics data and clinical information, enabling predictive models for immunotherapy and molecular target therapy. Next-gen sequencing reveals mutations and oncogenic pathways, with AI extracting insights from high-dimensional data. AI's integration into medical practice enhances diagnostics, catalyzing healthcare transformation. The synergy of nanotechnology and AI revolutionizes cancer management and reshapes medical practice.